The purpose of this study was to assess the anti‐tumor effects of zaltoprofen via regulation of MMP2 and PPARγ activity, and examine whether zaltoprofen could be a novel therapeutic agent in human chondrosarcoma. Here, PPARG is linked to neoplasm.